Researchers have begun trial testing an experimental stem cell treatment against the best available biologic therapies for severe forms of relapsing multiple sclerosis (MS). The trial, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), will compare the safety, efficacy, and cost-effectiveness of the two therapeutic approaches.

Read more of the article, here.